248 related articles for article (PubMed ID: 26027246)
1. [Familial partial lipodystrophy (Dunnigan syndrome) due to LMNA gene mutation: The first description of its clinical case in Russia].
Sorkina EL; Kalashnikova MF; Melnichenko GA; Tyulpakov AN
Ter Arkh; 2015; 87(3):83-87. PubMed ID: 26027246
[TBL] [Abstract][Full Text] [Related]
2. Dunnigan-type familial partial lipodystrophy associated with the heterozygous R482W mutation in LMNA gene - case study of three women from one family.
Nabrdalik K; Strózik A; Minkina-Pędras M; Jarosz-Chobot P; Młynarski W; Grzeszczak W; Gumprecht J
Endokrynol Pol; 2013; 64(4):306-11. PubMed ID: 24002959
[TBL] [Abstract][Full Text] [Related]
3. Lipodystrophy: an unusual diagnosis in a case of oligomenorrhea and hirsutism.
Keller J; Subramanyam L; Simha V; Gustofson R; Minjarez D; Garg A
Obstet Gynecol; 2009 Aug; 114(2 Pt 2):427-431. PubMed ID: 19622949
[TBL] [Abstract][Full Text] [Related]
4. A case of familial partial lipodystrophy caused by a novel lamin A/C (LMNA) mutation in exon 1 (D47N).
Kutbay NO; Yurekli BS; Onay H; Altay CT; Atik T; Hekimsoy Z; Saygili F; Akinci B
Eur J Intern Med; 2016 Apr; 29():37-9. PubMed ID: 26775134
[TBL] [Abstract][Full Text] [Related]
5. Familial partial lipodystrophy presenting as metabolic syndrome.
Chan D; McIntyre AD; Hegele RA; Don-Wauchope AC
J Clin Lipidol; 2016; 10(6):1488-1491. PubMed ID: 27919367
[TBL] [Abstract][Full Text] [Related]
6. Long-term improvement of metabolic control with pioglitazone in a woman with diabetes mellitus related to Dunnigan syndrome: a case report.
Collet-Gaudillat C; Billon-Bancel A; Beressi JP
Diabetes Metab; 2009 Apr; 35(2):151-4. PubMed ID: 19249234
[TBL] [Abstract][Full Text] [Related]
7. [A complex case of diabetes due to LMNA mutation].
Ambonville C; Bouldouyre MA; Laforêt P; Richard P; Benveniste O; Vigouroux C
Rev Med Interne; 2017 Oct; 38(10):695-699. PubMed ID: 28545855
[TBL] [Abstract][Full Text] [Related]
8. Familial partial lipodystrophy due to the LMNA R482W mutation with multinodular goitre, extrapyramidal syndrome and primary hyperaldosteronism.
Vantyghem MC; Faivre-Defrance F; Marcelli-Tourvieille S; Fermon C; Evrard A; Bourdelle-Hego MF; Vigouroux C; Defebvre L; Delemer B; Wemeau JL
Clin Endocrinol (Oxf); 2007 Aug; 67(2):247-9. PubMed ID: 17524034
[TBL] [Abstract][Full Text] [Related]
9. Polycystic ovary syndrome in familial partial lipodystrophy type 2 (FPLD2): basic and clinical aspects.
Gambineri A; Zanotti L
Nucleus; 2018; 9(1):392-397. PubMed ID: 30131000
[TBL] [Abstract][Full Text] [Related]
10. Fertility and obstetrical complications in women with LMNA-related familial partial lipodystrophy.
Vantyghem MC; Vincent-Desplanques D; Defrance-Faivre F; Capeau J; Fermon C; Valat AS; Lascols O; Hecart AC; Pigny P; Delemer B; Vigouroux C; Wemeau JL
J Clin Endocrinol Metab; 2008 Jun; 93(6):2223-9. PubMed ID: 18364375
[TBL] [Abstract][Full Text] [Related]
11. A novel phenotypic expression associated with a new mutation in LMNA gene, characterized by partial lipodystrophy, insulin resistance, aortic stenosis and hypertrophic cardiomyopathy.
Araújo-Vilar D; Lado-Abeal J; Palos-Paz F; Lattanzi G; Bandín MA; Bellido D; Domínguez-Gerpe L; Calvo C; Pérez O; Ramazanova A; Martínez-Sánchez N; Victoria B; Costa-Freitas AT
Clin Endocrinol (Oxf); 2008 Jul; 69(1):61-8. PubMed ID: 18031308
[TBL] [Abstract][Full Text] [Related]
12. Lipodystrophy-linked LMNA p.R482W mutation induces clinical early atherosclerosis and in vitro endothelial dysfunction.
Bidault G; Garcia M; Vantyghem MC; Ducluzeau PH; Morichon R; Thiyagarajah K; Moritz S; Capeau J; Vigouroux C; Béréziat V
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2162-71. PubMed ID: 23846499
[TBL] [Abstract][Full Text] [Related]
13. Familial partial lipodystrophy as differential diagnosis of polycystic ovary syndrome.
Lewandowski KC; Lewiński A; Dąbrowska K; Jakubowski L; Gach A
Endokrynol Pol; 2015; 66(6):550-4. PubMed ID: 26662654
[TBL] [Abstract][Full Text] [Related]
14. Regional Body Fat Changes and Metabolic Complications in Children With Dunnigan Lipodystrophy-Causing LMNA Variants.
Patni N; Li X; Adams-Huet B; Vasandani C; Gomez-Diaz RA; Garg A
J Clin Endocrinol Metab; 2019 Apr; 104(4):1099-1108. PubMed ID: 30418556
[TBL] [Abstract][Full Text] [Related]
15. A LMNA splicing mutation in two sisters with severe Dunnigan-type familial partial lipodystrophy type 2.
Morel CF; Thomas MA; Cao H; O'Neil CH; Pickering JG; Foulkes WD; Hegele RA
J Clin Endocrinol Metab; 2006 Jul; 91(7):2689-95. PubMed ID: 16636128
[TBL] [Abstract][Full Text] [Related]
16. Clinical presentations, metabolic abnormalities and end-organ complications in patients with familial partial lipodystrophy.
Akinci B; Onay H; Demir T; Savas-Erdeve Ş; Gen R; Simsir IY; Keskin FE; Erturk MS; Uzum AK; Yaylali GF; Ozdemir NK; Atik T; Ozen S; Yurekli BS; Apaydin T; Altay C; Akinci G; Demir L; Comlekci A; Secil M; Oral EA
Metabolism; 2017 Jul; 72():109-119. PubMed ID: 28641778
[TBL] [Abstract][Full Text] [Related]
17. FPLD2 LMNA mutation R482W dysregulates iPSC-derived adipocyte function and lipid metabolism.
Friesen M; Cowan CA
Biochem Biophys Res Commun; 2018 Jan; 495(1):254-260. PubMed ID: 29108996
[TBL] [Abstract][Full Text] [Related]
18. Dunnigan lipodystrophy syndrome: French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins).
Mosbah H; Donadille B; Vatier C; Janmaat S; Atlan M; Badens C; Barat P; Béliard S; Beltrand J; Ben Yaou R; Bismuth E; Boccara F; Cariou B; Chaouat M; Charriot G; Christin-Maitre S; De Kerdanet M; Delemer B; Disse E; Dubois N; Eymard B; Fève B; Lascols O; Mathurin P; Nobécourt E; Poujol-Robert A; Prevost G; Richard P; Sellam J; Tauveron I; Treboz D; Vergès B; Vermot-Desroches V; Wahbi K; Jéru I; Vantyghem MC; Vigouroux C
Orphanet J Rare Dis; 2022 Apr; 17(Suppl 1):170. PubMed ID: 35440056
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic diversity and glucocorticoid sensitivity in patients with familial partial lipodystrophy type 2.
Resende ATP; Martins CS; Bueno AC; Moreira AC; Foss-Freitas MC; de Castro M
Clin Endocrinol (Oxf); 2019 Jul; 91(1):94-103. PubMed ID: 30954027
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic Value of Anthropometric Measurements for Familial Partial Lipodystrophy, Dunnigan Variety.
Vasandani C; Li X; Sekizkardes H; Adams-Huet B; Brown RJ; Garg A
J Clin Endocrinol Metab; 2020 Jul; 105(7):2132-41. PubMed ID: 32193531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
